Copertina

Return to SENDer: The Submitted Electronic Data for Nonclinical Cardiovascular Studies is Not Facilitating Transparency, Translation or Innovation

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Matthew M. Abernathy, Derek D. Best, Derek J. Leishman
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The Efficacy, Effectiveness, and Efficiency of Integrated QTc Assessment: Rationalizing Approaches to New Drug Modalities
di: Matthew M. Abernathy, et al.
Pubblicazione: (2024)

Does Changing the Context of Use Change the Value Proposition of CiPA ?
di: Charles T. Benson, et al.
Pubblicazione: (2026)

The Open Hand Initiative: Facilitating the Use of Real‐World Evidence in Regulatory Submissions Through Collaboration and Transparency
di: Elodie Baumfeld Andre, et al.
Pubblicazione: (2024)

Analysis of Real‐World Data Utilization in the Orphan Drug Approval Process: Focusing on New Drug Marketing Applications Submitted to the FDA
di: Minji Kim, et al.
Pubblicazione: (2026)

Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs
di: Hyunwoo Koo, et al.
Pubblicazione: (2025)

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
di: Aaron S. Devanathan, et al.
Pubblicazione: (2025)

Causal Effects of Hydrophilic Bile Acids on Carfilzomib‐Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study
di: Samia Shabnaz, et al.
Pubblicazione: (2026)

Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal Pain
di: Sachalee Campbell, et al.
Pubblicazione: (2026)

The Future of Clinical Translational Pharmacology
di: Matthew L. Rizk, et al.
Pubblicazione: (2026)

Sex and the Kidney Drug‐Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?
di: Aarzoo Thakur, et al.
Pubblicazione: (2024)

Reply to “On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation”
di: Gianmario Candore, et al.
Pubblicazione: (2026)

History and Evolution of Innovations in Clinical Pharmacology
di: Lawrence J. Lesko, et al.
Pubblicazione: (2025)

Comparison of Regression and Categorical Analysis for Pharmacokinetic Data From Renal Impairment Studies
di: Gerald Chun‐To So, et al.
Pubblicazione: (2025)

Transcranial Magnetic Stimulation as a Translational Biomarker in Early‐Phase Anti‐Seizure Medication Development: A Randomized, Double‐Blind, Placebo‐Controlled Study in Generalized Epilepsy
di: Catherine M. E. de Cuba, et al.
Pubblicazione: (2026)

Information Bias in Electronic Health Records and Administrative Claims Data: A Targeted Review of the Recent Literature
di: Patrick J. Arena, et al.
Pubblicazione: (2025)

Minimizing Racial Algorithmic Bias when Predicting Electronic Health Record Data Completeness
di: Priyanka Anand, et al.
Pubblicazione: (2025)

Development and Validation of the Pharmacological Statin‐Associated Muscle Symptoms Risk Stratification Score Using Electronic Health Record Data
di: Boguang Sun, et al.
Pubblicazione: (2024)

Evaluating Unmeasured Confounding Factors in Claims Data Using Linked Electronic Health Records: A Proof‐of‐Principle Analysis
di: Sushama Kattinakere Sreedhara, et al.
Pubblicazione: (2026)

HIV Pharmacology Data Repository: Setting the New Information‐Sharing Standard for Clinical and Preclinical Pharmacokinetic Studies
di: Lauren A.R. Tompkins, et al.
Pubblicazione: (2025)

Risk of Malignancies and Major Adverse Cardiovascular Events Related to JAK Inhibitors in Rheumatoid Arthritis: A Meta‐Analysis
di: Hongmei Duan, et al.
Pubblicazione: (2025)

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data
di: Eissa A. Jafari, et al.
Pubblicazione: (2025)

The Role for Clinical Translational Pharmacology in Advancing Pharmacoequity
di: Sonya Tang Girdwood, et al.
Pubblicazione: (2025)

Crossing the Chasm: How to Approach Translational Pharmacokinetic–Pharmacodynamic Modeling of Phage Dosing
di: Gauri G. Rao, et al.
Pubblicazione: (2024)

Identification of a Safe and Tolerable Carbamazepine Dosing Paradigm that Facilitates Effective Evaluation of CYP3A4 Induction
di: Amita Datta‐Mannan, et al.
Pubblicazione: (2024)

Drug‐Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected Electronic Data Sources
di: Anna Maria Wermund, et al.
Pubblicazione: (2025)

Establishing a Validation Framework of Treatment Discontinuation in Claims Data Using Natural Language Processing and Electronic Health Records
di: Chun‐Ting Yang, et al.
Pubblicazione: (2025)

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
di: Karthik Venkatakrishnan, et al.
Pubblicazione: (2025)

Translational Modeling as a Tool to Evaluate the Effectiveness of Nalmefene in a Community Setting: A Critical Perspective
di: Celine M. Laffont, et al.
Pubblicazione: (2025)

A Fast Path from Innovation to Safe and Effective Medicines
di: Peter Arlett, et al.
Pubblicazione: (2025)

Correction to “Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies”
Pubblicazione: (2025)

Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes
di: Anu Patel, et al.
Pubblicazione: (2024)

Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data
di: Maria J. Alfonso Arvez, et al.
Pubblicazione: (2025)

A Translational Model‐Based Meta‐Analysis to Predict Tremor Incidence Associated with Serotonin Reuptake Transporter Inhibition
di: Sheetal K. Panday, et al.
Pubblicazione: (2025)

Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making
di: Linh M. Van, et al.
Pubblicazione: (2025)

ISABELA Studies: Plasma Exposure and Target Engagement Do Not Explain the Lack of Efficacy of Ziritaxestat in Patients with Idiopathic Pulmonary Fibrosis
di: Amit Taneja, et al.
Pubblicazione: (2024)

Transforming the Discovery of Targeted Protein Degraders: The Translational Power of Predictive PK/PD Modeling
di: Robin Thomas Ulrich Haid, et al.
Pubblicazione: (2024)

Extracellular Vesicles as Immunotherapeutic Mediators in Gastrointestinal Cancers and Diseases: From Mechanisms to Clinical Translation
di: Xiaona Lin, et al.
Pubblicazione: (2026)

Emulating Comparative Oncology Trials With Real‐World Evidence Studies ( ENCORE ): Process Development and Methodological Considerations for Oncology Real‐World Data
di: Janick Weberpals, et al.
Pubblicazione: (2026)

Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations
di: Jorge Madrid Paredes, et al.
Pubblicazione: (2024)

The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions
di: Cécile Ollivier, et al.
Pubblicazione: (2024)